Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

Giuseppe Lia, PhD, Clara Di Vito, PhD, Marta Tapparo, PhD, Stefania Bruno, Elisa Zaghi, Michela Calvi, Lucia Brunello, Jacopo Mariotti, MD, Lorenzo Comba, Luisa Giaccone, Martina Fascì, Mario Boccadoro, Andrea Evangelista, MSc, Luca Castagna, MD, Giovanni Camussi, Domenico Mavilio, Benedetto Bruno, MD

Blood (2019) 134 (Supplement_1): 598.

https://doi.org/10.1182/blood-2019-126521

Published: 2019

Journal Articles

USP Potency Adjusted Bovine Mucosal Heparins (BMH) Are Comparable to Porcine Mucosal Heparin (PMH) at Equivalent Levels

Ahmed Kouta, Walter Jeske, PhD, Rick Duff, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 165.

https://doi.org/10.1182/blood-2019-131943

Published: 2019

Journal Articles

Potency Equated Porcine and Bovine Mucosal Heparin Are Bioequivalent in Terms of Biochemical and Pharmacological Effects

Nausheen Baig, Ahmed Kouta, Fakiha Siddiqui, Ambar Farooqui, Debra Hoppensteadt, PhD, Walter Jeske, PhD, Omer Iqbal, MD, Cassie Bacher, Sharan Krishnappan, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 3665.

https://doi.org/10.1182/blood-2019-126075

Published: 2019

Journal Articles

Laboratory Assays to Address the Problem of Heparin-Protamine Balance Following Neonatal Open Heart Surgery

Julie A. Peterson, PhD, Susan A. Maroney, DVM, PhD, Wes Zwifelhofer, BS, Jeremy P. Wood, PhD, Rachel Bercovitz, MD MS, Ronald K. Woods, MD PhD, Alan E. Mast, MDPhD

Blood (2017) 130 (Supplement 1): 1111.

https://doi.org/10.1182/blood.V130.Suppl_1.1111.1111

Published: 2017

Journal Articles

Incidence of Bleeding Events in Acute Myeloid Leukemia (AML) Patients Receiving Anticoagulation Therapy for Treatment of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) Who Are Also Undergoing Induction or Re-Induction Therapy

Meagan Scott, PharmD, Maho Hibino, PharmD, Marie Cavalier, PharmD, Bayard L. Powell, MD, Dianna S. Howard, MD, Leslie Renee Ellis, MD, Rupali Bhave, MD, Susan Lyerly, P.A.-C., Megan Manuel, M.S.N, Sarah Dralle, M.S.N., Timothy S Pardee, MD PhD

Blood (2017) 130 (Supplement 1): 2091.

https://doi.org/10.1182/blood.V130.Suppl_1.2091.2091

Published: 2017

Journal Articles

Platelet Factor 4 (PF4)-Mediated Neutrophil Extracellular Trap Compaction Limits Endothelial Injury and Promotes Survival Following Lipopolysaccharide Challenge

Kandace Gollomp, MD, Ian Johnston, BS, Minna Kim, Li Zhai, Guohua Zhao, M. Anna Kowalska, PhD, Mortimer Poncz, MD

Blood (2017) 130 (Supplement 1): 997.

https://doi.org/10.1182/blood.V130.Suppl_1.997.997

Published: 2017

Journal Articles

Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram

Surbhi Saini, MD, Katherine L Harsh, BS, Joseph R Stanek, MS, Sarah O'Brien, MD MSc, Amy L. Dunn, MD, Riten Kumar, MD MSc

Blood (2017) 130 (Supplement 1): 701.

https://doi.org/10.1182/blood.V130.Suppl_1.701.701

Published: 2017

Journal Articles

Plasma Proteolytic Cascade Activation and Control during Neonatal Cardiopulmonary Bypass Surgery

Susan A. Maroney, DVM, PhD, Julie A. Peterson, PhD, Wes Zwifelhofer, BS, Rachel Bercovitz, MD MS, Ronald K. Woods, MD PhD, Alan E. Mast, MDPhD

Blood (2017) 130 (Supplement 1): 2356.

https://doi.org/10.1182/blood.V130.Suppl_1.2356.2356

Published: 2017

Journal Articles

Protamine Sulfate Interacts with Partially Activated Forms of Factor V Which Contributes to Its Paradoxical Anticoagulant Effect

Teodolinda Petrillo, PhD, Brenna C Remick, Michelle D. Ho, BS, Rodney M Camire, PhD

Blood (2017) 130 (Supplement 1): 2337.

https://doi.org/10.1182/blood.V130.Suppl_1.2337.2337

Published: 2017

Journal Articles

Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA

Manu Thomas Kalathottukaren, Libin Abraham, Piyushkumar R. Kapopara, Benjamin F. L. Lai, Rajesh A. Shenoi, Federico I. Rosell, Edward M. Conway, Edward L. G. Pryzdial, James H. Morrissey, Charles A. Haynes, Jayachandran N. Kizhakkedathu

Blood (2017) 129 (10): 1368–1379.

https://doi.org/10.1182/blood-2016-10-747915

Published: 2017

Includes: Supplemental data

Journal Articles

Novel ELISA-Based Assay for Detection of Complement Activation By PF4/Heparin Complexes

Sanjay Khandelwal, PhD, Johnson M Alexandra, BS, Grace M. Lee, MD, Gowthami M Arepally, MD

Blood (2016) 128 (22): 3734.

https://doi.org/10.1182/blood.V128.22.3734.3734

Published: 2016

Journal Articles

RNA Aptamer Against FXa Synergizes with FXa Catalytic Site Inhibitors to Effectively and Reversibly Anticoagulate Blood in an Ex Vivo Oxygenator Circuit

Ruwan Gunaratne, MA, James Frederiksen, MD, Nabil K. Thalji, BS, Michelle D Ho, Gowthami M Arepally, MD, Rodney M. Camire, PhD, Bruce A. Sullenger, PhD

Blood (2016) 128 (22): 3823.

https://doi.org/10.1182/blood.V128.22.3823.3823

Published: 2016

Journal Articles

Restoration of Procoagulant Factor Levels after Cardiac Surgery Causes Thrombin Generation to Rise to Thrombotic Levels

Romy Kremers, MSc, Yvonne Bosch, MSc, Saartje Bloemen, PhD, Bas De Laat, MD PhD, Rob Wagenvoord, PhD, Raed Al Dieri, PhDPharmD, Coenraad Hemker, MD PhD

Blood (2015) 126 (23): 1143.

https://doi.org/10.1182/blood.V126.23.1143.1143

Published: 2015

Journal Articles

Reversal of Heparin-Induced Anticoagulation By Andexanet Alfa, a Universal Antidote for Factor Xa Inhibitors

Genmin Lu, PhD, Joyce Lin, BS, John T. Curnutte, MDPhD, Pamela B. Conley, PhD

Blood (2015) 126 (23): 2329.

https://doi.org/10.1182/blood.V126.23.2329.2329

Published: 2015

Journal Articles

Characterization of Human and Murine Anti-Protamine/Heparin Antibodies

Grace M. Lee, MD, Manali Joglekar, MS, Sanjay Khandelwal, Rui Qi, BS, Lubica Rauova, MD PhD, Gowthami M Arepally, MD

Blood (2015) 126 (23): 3461.

https://doi.org/10.1182/blood.V126.23.3461.3461

Published: 2015

Journal Articles

Biologic Activities of Protamine/Heparin Antibodies

Grace M. Lee, MD, Manali V. Joglekar, Rui Qi, Gowthami M Arepally, MD

Blood (2014) 124 (21): 2784.

https://doi.org/10.1182/blood.V124.21.2784.2784

Published: 2014

Journal Articles

A Universal Heparin Antidote with Negligible Effect on Fibrin(ogen) and Plasma Coagulation

Manu Thomas Kalathottukaren, PhDcandidate, Rajesh A Shenoi, PhD, Lai FL Benjamin, MSc, Fred Rosell, PhD, Jayachandran N Kizhakkedathu, PhD, Edward L.G. Pryzdial, PhD

Blood (2014) 124 (21): 4231.

https://doi.org/10.1182/blood.V124.21.4231.4231

Published: 2014

Journal Articles

Characterization of Antithrombin-Specific RNA Aptamers for Use in Anticoagulant Therapy

Yolanda Fortenberry, PhD

Blood (2014) 124 (21): 4236.

https://doi.org/10.1182/blood.V124.21.4236.4236

Published: 2014

Journal Articles

Laboratory Assessment of Anti-Coagulant Properties of a Von Willebrand Factor Targeted Aptamer

Deborah A. Lewis, PhD, Shahid M. Nimjee, MD, PhD, George A. Pitoc, D.V.M., M.S., Shoeb Khan, PhD, Richard C. Becker, MD, Bruce A. Sullenger, PhD, Thomas L. Ortel, MD, PhD

Blood (2014) 124 (21): 4279.

https://doi.org/10.1182/blood.V124.21.4279.4279

Published: 2014

NARROW

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

USP Potency Adjusted Bovine Mucosal Heparins (BMH) Are Comparable to Porcine Mucosal Heparin (PMH) at Equivalent Levels

Potency Equated Porcine and Bovine Mucosal Heparin Are Bioequivalent in Terms of Biochemical and Pharmacological Effects

Laboratory Assays to Address the Problem of Heparin-Protamine Balance Following Neonatal Open Heart Surgery

Incidence of Bleeding Events in Acute Myeloid Leukemia (AML) Patients Receiving Anticoagulation Therapy for Treatment of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) Who Are Also Undergoing Induction or Re-Induction Therapy

Platelet Factor 4 (PF4)-Mediated Neutrophil Extracellular Trap Compaction Limits Endothelial Injury and Promotes Survival Following Lipopolysaccharide Challenge

Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram

Plasma Proteolytic Cascade Activation and Control during Neonatal Cardiopulmonary Bypass Surgery

Protamine Sulfate Interacts with Partially Activated Forms of Factor V Which Contributes to Its Paradoxical Anticoagulant Effect

Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA

Novel ELISA-Based Assay for Detection of Complement Activation By PF4/Heparin Complexes

RNA Aptamer Against FXa Synergizes with FXa Catalytic Site Inhibitors to Effectively and Reversibly Anticoagulate Blood in an Ex Vivo Oxygenator Circuit

Extracellular Vesicles as Potential Biomarker for Acute Graft-Versus-Host-Disease

Restoration of Procoagulant Factor Levels after Cardiac Surgery Causes Thrombin Generation to Rise to Thrombotic Levels

Reversal of Heparin-Induced Anticoagulation By Andexanet Alfa, a Universal Antidote for Factor Xa Inhibitors

Characterization of Human and Murine Anti-Protamine/Heparin Antibodies

Biologic Activities of Protamine/Heparin Antibodies

A Universal Heparin Antidote with Negligible Effect on Fibrin(ogen) and Plasma Coagulation

Characterization of Antithrombin-Specific RNA Aptamers for Use in Anticoagulant Therapy

Laboratory Assessment of Anti-Coagulant Properties of a Von Willebrand Factor Targeted Aptamer

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only